| UniProt ID | ACL6B_HUMAN | |
|---|---|---|
| UniProt AC | O94805 | |
| Protein Name | Actin-like protein 6B | |
| Gene Name | ACTL6B | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 426 | |
| Subcellular Localization | Nucleus . | |
| Protein Description | Involved in transcriptional activation and repression of select genes by chromatin remodeling (alteration of DNA-nucleosome topology). Component of SWI/SNF chromatin remodeling complexes that carry out key enzymatic activities, changing chromatin structure by altering DNA-histone contacts within a nucleosome in an ATP-dependent manner. Belongs to the neuron-specific chromatin remodeling complex (nBAF complex), as such plays a role in remodeling mononucleosomes in an ATP-dependent fashion, and is required for postmitotic neural development and dendritic outgrowth. During neural development a switch from a stem/progenitor to a postmitotic chromatin remodeling mechanism occurs as neurons exit the cell cycle and become committed to their adult state. The transition from proliferating neural stem/progenitor cells to postmitotic neurons requires a switch in subunit composition of the npBAF and nBAF complexes. As neural progenitors exit mitosis and differentiate into neurons, npBAF complexes which contain ACTL6A/BAF53A and PHF10/BAF45A, are exchanged for homologous alternative ACTL6B/BAF53B and DPF1/BAF45B or DPF3/BAF45C subunits in neuron-specific complexes (nBAF). The npBAF complex is essential for the self-renewal/proliferative capacity of the multipotent neural stem cells. The nBAF complex along with CREST plays a role regulating the activity of genes essential for dendrite growth. ACTL6B/BAF53B is not essential for assembly of the nBAF complex but is required for targeting the complex and CREST to the promoter of genes essential for dendritic growth (By similarity).. | |
| Protein Sequence | MSGGVYGGDEVGALVFDIGSFSVRAGYAGEDCPKADFPTTVGLLAAEEGGGLELEGDKEKKGKIFHIDTNALHVPRDGAEVMSPLKNGMIEDWECFRAILDHTYSKHVKSEPNLHPVLMSEAPWNTRAKREKLTELMFEQYNIPAFFLCKTAVLTAFANGRSTGLVLDSGATHTTAIPVHDGYVLQQGIVKSPLAGDFISMQCRELFQEMAIDIIPPYMIAAKEPVREGAPPNWKKKEKLPQVSKSWHNYMCNEVIQDFQASVLQVSDSPYDEQVAAQMPTVHYEMPNGYNTDYGAERLRIPEGLFDPSNVKGLSGNTMLGVGHVVTTSIGMCDIDIRPGLYGSVIVTGGNTLLQGFTDRLNRELSQKTPPSMRLKLIASNSTMERKFSPWIGGSILASLGTFQQMWISKQEYEEGGKQCVERKCP | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Phosphorylation | ------MSGGVYGGD ------CCCCCCCCC | 44.23 | - | |
| 2 | Acetylation | ------MSGGVYGGD ------CCCCCCCCC | 44.23 | - | |
| 6 | Phosphorylation | --MSGGVYGGDEVGA --CCCCCCCCCCCEE | 20.75 | 18491316 | |
| 83 | Phosphorylation | RDGAEVMSPLKNGMI CCCCCCCCCCCCCCC | 32.05 | - | |
| 104 | Phosphorylation | RAILDHTYSKHVKSE HHHHHHCHHHCCCCC | 16.59 | 25884760 | |
| 126 | Phosphorylation | MSEAPWNTRAKREKL CCCCCCCHHHHHHHH | 28.30 | - | |
| 134 | Phosphorylation | RAKREKLTELMFEQY HHHHHHHHHHHHHHC | 37.83 | 24719451 | |
| 141 | Phosphorylation | TELMFEQYNIPAFFL HHHHHHHCCCCHHHH | 14.09 | 27174698 | |
| 155 | Phosphorylation | LCKTAVLTAFANGRS HHHHHHHHHHHCCCC | 17.09 | 24719451 | |
| 183 | Phosphorylation | AIPVHDGYVLQQGIV EEEECCCEEEEECEE | 12.21 | - | |
| 191 | Acetylation | VLQQGIVKSPLAGDF EEEECEECCCCCCCH | 44.42 | 26051181 | |
| 204 | Methylation | DFISMQCRELFQEMA CHHHHHHHHHHHHHH | 27.11 | - | |
| 244 | Phosphorylation | KEKLPQVSKSWHNYM HHHCCCCCHHHHHHH | 18.74 | 20068231 | |
| 366 | Phosphorylation | DRLNRELSQKTPPSM HHHHHHHHHCCCCHH | 25.52 | 29083192 | |
| 368 | Ubiquitination | LNRELSQKTPPSMRL HHHHHHHCCCCHHHE | 60.67 | 21906983 | |
| 368 | Acetylation | LNRELSQKTPPSMRL HHHHHHHCCCCHHHE | 60.67 | 25953088 | |
| 369 | Phosphorylation | NRELSQKTPPSMRLK HHHHHHCCCCHHHEE | 32.56 | 20860994 | |
| 372 | Phosphorylation | LSQKTPPSMRLKLIA HHHCCCCHHHEEEHH | 20.10 | 20860994 | |
| 382 | Phosphorylation | LKLIASNSTMERKFS EEEHHCCCCCCCCCC | 27.00 | 23403867 | |
| 383 | Phosphorylation | KLIASNSTMERKFSP EEHHCCCCCCCCCCC | 27.57 | 23403867 | |
| 395 | Phosphorylation | FSPWIGGSILASLGT CCCCCCHHHHHHHHH | 14.82 | 22210691 | |
| 399 | Phosphorylation | IGGSILASLGTFQQM CCHHHHHHHHHHHHH | 24.72 | 22210691 | |
| 413 | Phosphorylation | MWISKQEYEEGGKQC HHHCHHHHHCCHHCC | 19.45 | 22210691 | |
| 418 | Ubiquitination | QEYEEGGKQCVERKC HHHHCCHHCCCCCCC | 51.92 | 30230243 | |
| 418 | Acetylation | QEYEEGGKQCVERKC HHHHCCHHCCCCCCC | 51.92 | 26051181 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ACL6B_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ACL6B_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ACL6B_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| CTBP1_HUMAN | CTBP1 | genetic | 12565893 | |
| CTBP1_HUMAN | CTBP1 | physical | 12565893 | |
| A4_HUMAN | APP | physical | 21832049 | |
| MED14_HUMAN | MED14 | physical | 26344197 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...